Published in J Dermatol on September 01, 2010
WHO-EORTC classification for cutaneous lymphomas. Blood (2005) 12.14
Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood (2007) 2.82
Wells syndrome in adults and children: a report of 19 cases. Arch Dermatol (2006) 1.94
Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. Blood (2005) 1.83
Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC). Arch Dermatol (2008) 1.78
Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. J Allergy Clin Immunol (2007) 1.75
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol (2006) 1.70
Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases. Medicine (Baltimore) (2014) 1.70
Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net. Orphanet J Rare Dis (2013) 1.67
Treatment of refractory pemphigus with the anti-CD20 monoclonal antibody (rituximab). Dermatology (2007) 1.60
Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol (2013) 1.56
Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications. Intern Emerg Med (2009) 1.53
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol (2005) 1.51
Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy. Inflamm Bowel Dis (2014) 1.39
Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II. Haematologica (2004) 1.29
Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer (2003) 1.15
Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation. Transplantation (2009) 1.14
Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion. Blood (2011) 1.12
Quantitative and functional defects of dendritic cells in classic Kaposi's sarcoma. Clin Immunol (2006) 1.06
Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis. Histol Histopathol (2009) 0.98
Skin involvement in cutaneous and systemic vasculitis. Autoimmun Rev (2012) 0.98
Pyoderma gangrenosum: study of 21 patients and proposal of a 'clinicotherapeutic' classification. J Dermatolog Treat (2010) 0.98
Cutaneous extranodal NK/T-cell lymphoma: a clinicopathologic study of 5 patients with array-based comparative genomic hybridization. Blood (2010) 0.98
Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene. JAMA Dermatol (2013) 0.97
Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome following bowel bypass surgery. Dermatology (2012) 0.95
Giant nevoid hypertrichosis in an Iranian girl. Pediatr Dermatol (2002) 0.95
Necrotic erythema nodosum leprosum as the first manifestation of borderline lepromatous leprosy. Arch Dermatol (2008) 0.94
Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type. J Invest Dermatol (2008) 0.94
Medallion-like dermal dendrocyte hamartoma: a case misdiagnosed as neurofibroma. Pediatr Dermatol (2010) 0.93
Cutaneous lymphoid hyperplasia associated with Leishmania panamensis infection. Acta Derm Venereol (2010) 0.93
Factors of delay in the diagnosis of melanoma. Eur J Dermatol (2003) 0.92
Familial syringoma: report of two cases with a published work review and the unique association with steatocystoma multiplex. J Dermatol (2009) 0.91
Hypereosinophilic syndrome, Churg-Strauss syndrome and parasitic diseases: possible links between eosinophilia and thrombosis. Curr Vasc Pharmacol (2012) 0.90
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients. Cancer (2005) 0.88
Anatomic location and histopathologic subtype of basal cell carcinomas in adults younger than 40 or 90 and older: any difference? Dermatol Surg (2009) 0.88
Unusual variants of non-Langerhans cell histiocytoses. J Am Acad Dermatol (2007) 0.88
Cutaneous lupus erythematosus induced by adalimumab. J Dermatol (2010) 0.87
Expression of tissue factor by eosinophils in patients with chronic urticaria. Int Arch Allergy Immunol (2008) 0.87
Primary cutaneous T-cell lymphoma expressing FOXP3: a case report supporting the existence of malignancies of regulatory T cells. J Am Acad Dermatol (2009) 0.87
Topical tacrolimus for the treatment of localized, idiopathic, newly diagnosed pyoderma gangrenosum. J Dermatolog Treat (2010) 0.86
Chordoma cutis. Eur J Dermatol (2004) 0.86
Oral and cutaneous findings are valuable diagnostic aids in Wegener's granulomatosis. Eur J Intern Med (2009) 0.86
Skin infection due to Alternaria species in kidney allograft recipients: report of a new case and review of the literature. J Nephrol (2006) 0.86
Basal cell carcinomas of the areola-nipple complex: case reports and review of the literature. J Dermatol (2003) 0.85
Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified. Leuk Lymphoma (2011) 0.85
Basosquamous cell carcinoma: a survey of 76 patients and a comparative analysis of basal cell carcinomas and squamous cell carcinomas. Eur J Dermatol (2013) 0.85
Cetuximab-induced acneiform eruption and the response to isotretinoin. Acta Derm Venereol (2008) 0.84
Anatomic location of Basal cell carcinomas may favor certain histologic subtypes. J Cutan Med Surg (2010) 0.83
Skin autoimmunity and blood coagulation. Autoimmunity (2010) 0.83
Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entity. Hum Pathol (2002) 0.82
Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response. Cancer Immunol Immunother (2013) 0.82
Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas. J Dermatol (2010) 0.81
Melanoma of the glans penis. Eur J Dermatol (2005) 0.81
Three cases of primary cutaneous lymphoblastic lymphoma: microarray-based comparative genomic hybridization and gene expression profiling studies with review of literature. Leuk Lymphoma (2011) 0.81
Spatial and temporal expression of POF1B, a gene expressed in epithelia. Gene Expr Patterns (2006) 0.80
Inflammation and coagulation in urticaria and angioedema. Curr Vasc Pharmacol (2012) 0.80
Expression of cell cycle regulatory proteins and analysis of apoptosis in normal nasal mucosa and in nasal polyps. Am J Rhinol (2006) 0.80
Dermatologic radiotherapy of primary cutaneous follicle center cell lymphoma. Eur J Dermatol (2003) 0.79
Autoantibody Profile of a Cohort of 78 Italian Patients with Mucous Membrane Pemphigoid: Correlation Between Reactivity Profile and Clinical Involvement. Acta Derm Venereol (2016) 0.79
Immune-mediated inflammatory reactions and tumors as skin side effects of inflammatory bowel disease therapy. Autoimmunity (2014) 0.79
C/EBPδ gene targets in human keratinocytes. PLoS One (2010) 0.79
Vulvar pyoderma gangrenosum with renal involvement. Eur J Dermatol (2012) 0.79
Can nonalcoholic steatohepatitis trigger porphyria cutanea tarda clinical manifestations? Intern Emerg Med (2008) 0.79
Activation of blood coagulation in autoimmune skin disorders. Expert Rev Clin Immunol (2009) 0.78
Cutaneous T-cell/histiocyte-rich B-cell lymphoma: a case report and review of the literature. Dermatology (2011) 0.78
CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11). Ann Hematol (2010) 0.78
Prevalence of Borrelia burgdorferi infection in a series of 98 primary cutaneous lymphomas. Oncologist (2011) 0.78
Sclerosing cholangitis and liver transplantation in Langerhans cell histiocytosis: a 14-year follow-up. Dermatology (2004) 0.78
Really synchronous cutaneous melanomas: serendipity or need for prevention? Eur J Dermatol (2009) 0.78
[Neonatal toxic erythema : clinico-epidemiologic characteristics and recent pathogenic hypothesis]. Pediatr Med Chir (2006) 0.77
Cytokeratin profile in basal cell carcinoma. Am J Dermatopathol (2008) 0.77
Basal cell carcinoma of the sole. J Dermatol (2005) 0.76
Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study. Thromb Haemost (2015) 0.76
Primary cutaneous follicular center cell lymphoma of the nose with maxillary sinus involvement in a pediatric patient. J Am Acad Dermatol (2005) 0.76
Photoletter to the editor: Exfoliative cheilitis associated with titanium dental implants and mercury amalgam. J Dermatol Case Rep (2011) 0.76
Cytokine and Chemokine Profile in Amicrobial Pustulosis of the Folds: Evidence for Autoinflammation. Medicine (Baltimore) (2015) 0.75
Paradoxical Autoinflammatory Skin Reaction to Tumor Necrosis Factor Alpha Blockers Manifesting as Amicrobial Pustulosis of the Folds in Patients With Inflammatory Bowel Diseases. Medicine (Baltimore) (2015) 0.75
Refractory linear IgA bullous dermatosis successfully treated with mycophenolate sodium. J Dermatolog Treat (2008) 0.75
Rationale and efficacy for the use of rituximab in paraneoplastic pemphigus. Expert Rev Clin Immunol (2008) 0.75
Mycosis fungoides mimicking erythema gyratum repens: an additional variant? Eur J Dermatol (2010) 0.75